Literature DB >> 12390600

Field evaluation of the CATT/Trypanosoma brucei gambiense on blood-impregnated filter papers for diagnosis of human African trypanosomiasis in southern Sudan.

F Chappuis1, A Pittet, P A Bovier, K Adams, V Godineau, S Y Hwang, E Magnus, P Büscher.   

Abstract

Most Human African Trypanosomiasis (HAT) control programmes in areas endemic for Trypanosoma brucei gambiense rely on a strategy of active mass screening with the Card Agglutination Test for Trypanosomiasis (CATT)/T. b. gambiense. We evaluated the performance, stability and reproducibility of the CATT/T. b. gambiense on blood-impregnated filter papers (CATT-FP) in Kajo-Keji County, South-Sudan, where some areas are inaccessible to mobile teams. The CATT-FP was performed with a group of 100 people with a positive CATT on whole blood including 17 confirmed HAT patients and the results were compared with the CATT on plasma (CATT-P). The CATT-FP was repeated on impregnated filter papers stored at ambient and refrigerated temperature for 1, 3, 7 and 14 days. Another 82 patients with HAT, including 78 with a positive parasitology, were tested with the CATT-FP and duplicate filter paper samples were sent to a reference laboratory to assess reproducibility. The CATT-FP was positive in 90 of 99 patients with HAT (sensitivity: 91%). It was less sensitive than the CATT-P (mean dilution difference: -2.5). There was no significant loss of sensitivity after storage for up to 14 days both at ambient and cool temperature. Reproducibility of the CATT-FP was found to be excellent (kappa: 0.84). The CATT-FP can therefore be recommended as a screening test for HAT in areas where the use of CATT-P is not possible. Further studies on larger population samples in different endemic foci are still needed before the CATT-FP can be recommended for universal use.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12390600     DOI: 10.1046/j.1365-3156.2002.00956.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  7 in total

1.  Diagnostic accuracy and feasibility of serological tests on filter paper samples for outbreak detection of T.b. gambiense human African trypanosomiasis.

Authors:  Epco Hasker; Pascal Lutumba; Dieudonné Mumba; Veerle Lejon; Phillipe Büscher; Victor Kande; Jean Jacques Muyembe; Joris Menten; Jo Robays; Marleen Boelaert
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

Review 2.  Options for field diagnosis of human african trypanosomiasis.

Authors:  François Chappuis; Louis Loutan; Pere Simarro; Veerle Lejon; Philippe Büscher
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

3.  Characterization of recombinant Trypanosoma brucei gambiense Translationally Controlled Tumor Protein (rTbgTCTP) and its interaction with Glossina midgut bacteria.

Authors:  Géraldine Bossard; Manon Bartoli; Marie-Laure Fardeau; Philippe Holzmuller; Bernard Ollivier; Anne Geiger
Journal:  Gut Microbes       Date:  2017-06-06

Review 4.  Human African trypanosomiasis in South Sudan: how can we prevent a new epidemic?

Authors:  José A Ruiz-Postigo; José R Franco; Mounir Lado; Pere P Simarro
Journal:  PLoS Negl Trop Dis       Date:  2012-05-29

5.  Integrating innovations: a qualitative analysis of referral non-completion among rapid diagnostic test-positive patients in Uganda's human African trypanosomiasis elimination programme.

Authors:  Shona J Lee; Jennifer J Palmer
Journal:  Infect Dis Poverty       Date:  2018-08-18       Impact factor: 4.520

Review 6.  Human african trypanosomiasis diagnosis in first-line health services of endemic countries, a systematic review.

Authors:  Patrick Mitashi; Epco Hasker; Veerle Lejon; Victor Kande; Jean-Jacques Muyembe; Pascal Lutumba; Marleen Boelaert
Journal:  PLoS Negl Trop Dis       Date:  2012-11-29

Review 7.  An overview of the clinical use of filter paper in the diagnosis of tropical diseases.

Authors:  Pieter W Smit; Ivo Elliott; Rosanna W Peeling; David Mabey; Paul N Newton
Journal:  Am J Trop Med Hyg       Date:  2013-12-23       Impact factor: 2.345

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.